Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential
Autor: | Saxena, P. R., Vries, P. De, Heiligers, J. P. C., VanDenBrink, A. Maassen, Bax, W. A., Barf, T., Wikstroem, H. |
---|---|
Zdroj: | European Journal of Pharmacology; 1996, Vol. 312 Issue: 1 p53-62, 10p |
Databáze: | Supplemental Index |
Externí odkaz: |